Valuation : QuidelOrtho Corporation

Market Cap 943M 813M 765M 697M 1.31B 89.49B 1.32B 9.04B 3.52B 45.52B 3.54B 3.46B 151B P/E 2026 *
-3.34x
P/E 2027 * -4.96x
Enterprise Value 3.66B 3.15B 2.97B 2.7B 5.08B 347B 5.11B 35.07B 13.65B 176B 13.72B 13.43B 585B EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.38x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-4.71%
1 week-8.64%
Current month-4.71%
1 month-18.01%
3 months+3.62%
6 months-39.53%
Current year-51.86%
1 week 13.6
Extreme 13.6
15.5
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
83.37
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
15/08/26 Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
15/07/26 Free

Chief Financial Officer

356,555 0.5251%
06/07/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-4.71%-8.64%-52.07%-83.56% 943M
-2.27%-1.06%+23.59%-34.98% 17.71B
-0.44%-7.58%-36.42%+54.88% 1.6B
-1.49%-1.46%-23.54%+16.91% 947M
-0.11%-0.16%+59.91%-7.37% 778M
+2.40%+0.09%-33.29%-45.77% 690M
+2.07%+8.62%-38.78%-46.21% 611M
-1.47%+9.60%-30.97%-32.52% 502M
-0.19%-3.18%+70.40%+49.79% 440M
-0.36%+0.49%-1.32%-11.97% 409M
Average -0.73%+0.29%-6.25%-14.08% 2.46B
Weighted average by Cap. -1.83%-0.13%+12.31%-26.78%

Financials

2026 *2027 *
Net sales 2.54B 2.19B 2.06B 1.88B 3.54B 241B 3.56B 24.41B 9.5B 123B 9.55B 9.35B 407B 2.59B 2.24B 2.1B 1.92B 3.6B 246B 3.62B 24.86B 9.68B 125B 9.73B 9.52B 415B
Net income -282M -243M -228M -208M -391M -26.72B -394M -2.7B -1.05B -13.59B -1.06B -1.03B -45.07B -190M -164M -154M -141M -265M -18.06B -266M -1.83B -710M -9.19B -714M -699M -30.46B
Net Debt 2.71B 2.34B 2.2B 2.01B 3.77B 257B 3.79B 26.02B 10.13B 131B 10.18B 9.96B 434B 2.62B 2.26B 2.13B 1.94B 3.65B 249B 3.67B 25.17B 9.8B 127B 9.85B 9.64B 420B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
01/09/26 $13.75 -4.71% 892,837
31/08/26 $14.43 -2.10% 948,545
28/08/26 $14.74 -3.79% 1,207,889
27/08/26 $15.32 +2.75% 816,144
26/08/26 $14.91 -0.93% 1,599,003
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
13.75USD
Average target price
14.67USD
Spread / Average Target
+6.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock